Cargando…
High-dose thiotepa-related neurotoxicity and the role of tramadol in children
BACKGROUND: Serious neurological adverse events (NAE) have occurred during treatment with high-dose thiotepa regimens of children with high-risk solid tumours. The objective was to assess the incidence of NAE related to high-dose thiotepa and to identify potential contributing factors that could exa...
Autores principales: | Maritaz, Christophe, Lemare, Francois, Laplanche, Agnes, Demirdjian, Sylvie, Valteau-Couanet, Dominique, Dufour, Christelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809829/ https://www.ncbi.nlm.nih.gov/pubmed/29433564 http://dx.doi.org/10.1186/s12885-018-4090-6 |
Ejemplares similares
-
High Dose Thiotepa in Patients with Relapsed or Refractory Osteosarcomas: Experience of the SFCE Group
por: Marec-Berard, Perrine, et al.
Publicado: (2014) -
Metastatic Medulloblastoma in Childhood: Chang's Classification Revisited
por: Dufour, Christelle, et al.
Publicado: (2012) -
Whither thiotepa (for patients in the USA)?
por: Dardis, Christopher, et al.
Publicado: (2015) -
Thiotepa in the treatment of advanced breast cancer.
por: Lyons, A. R., et al.
Publicado: (1965) -
Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials
por: Wieczorek, Aleksandra, et al.
Publicado: (2022)